Healthcare provider profile · identity verified

Stacey J Porterfield, DO

Osteopathic Manipulative Medicine · WHITE CITY, OR · NPI 1255300992

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	340	60
Atorvastatin Calcium	Atorvastatin Calcium	307	91
Amlodipine Besylate	Amlodipine Besylate	233	70
Omeprazole	Omeprazole	217	48
Lisinopril	Lisinopril	206	58
Gabapentin	Gabapentin	201	41
Losartan Potassium	Losartan Potassium	197	56
Levothyroxine Sodium	Levothyroxine Sodium	168	55
Albuterol Sulfate Hfa	Albuterol Sulfate	136	50
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	134	33
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	117	22
Metformin Hcl	Metformin Hcl	110	42
Trazodone Hcl	Trazodone Hcl	108	28
Duloxetine Hcl	Duloxetine Hcl	99	18
Rosuvastatin Calcium	Rosuvastatin Calcium	98	28
Tamsulosin Hcl	Tamsulosin Hcl	94	33
Metoprolol Succinate	Metoprolol Succinate	92	32
Meloxicam	Meloxicam	90	29
Tramadol Hcl	Tramadol Hcl	90	26
Quetiapine Fumarate	Quetiapine Fumarate	85	13
Fluoxetine Hcl	Fluoxetine Hcl	79	22
Furosemide	Furosemide	78	23
Metoprolol Tartrate	Metoprolol Tartrate	75	20
Pantoprazole Sodium	Pantoprazole Sodium	75	18
Hydrochlorothiazide	Hydrochlorothiazide	74	21
Ibuprofen	Ibuprofen	70	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	19
Potassium Chloride	Potassium Chloride	62	19
Oxycodone Hcl	Oxycodone Hcl	60	suppressed
Clonazepam	Clonazepam	59	16
Eliquis	Apixaban	59	15
Pravastatin Sodium	Pravastatin Sodium	55	18
Ezetimibe	Ezetimibe	54	15
Oxybutynin Chloride Er	Oxybutynin Chloride	52	suppressed
Testosterone Cypionate	Testosterone Cypionate	52	suppressed
Mirtazapine	Mirtazapine	50	14
Hydroxyzine Hcl	Hydroxyzine Hcl	49	18
Simvastatin	Simvastatin	48	12
Citalopram Hbr	Citalopram Hydrobromide	47	14
Baclofen	Baclofen	42	13
Famotidine	Famotidine	42	11
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	40	14
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	38	16
Jardiance	Empagliflozin	38	suppressed
Buspirone Hcl	Buspirone Hcl	37	suppressed
Atenolol	Atenolol	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	suppressed
Metformin Hcl Er	Metformin Hcl	33	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Lovastatin	Lovastatin	31	suppressed
Ozempic	Semaglutide	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Carvedilol	Carvedilol	30	12
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Sertraline Hcl	Sertraline Hcl	28	11
Clobetasol Propionate	Clobetasol Propionate	27	12
Triamcinolone Acetonide	Triamcinolone Acetonide	27	11
Methocarbamol	Methocarbamol	26	suppressed
Ondansetron Odt	Ondansetron	26	13
Fluticasone Propionate	Fluticasone Propionate	24	12
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	23	suppressed
Finasteride	Finasteride	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Diazepam	Diazepam	21	suppressed
Estradiol	Estradiol	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Colchicine	Colchicine	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Varenicline Tartrate	Varenicline Tartrate	17	11
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Cephalexin	Cephalexin	15	12
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Linzess	Linaclotide	14	suppressed
Modafinil	Modafinil	14	suppressed
Montelukast Sodium	Montelukast Sodium	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Budesonide Dr	Budesonide	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Lyrica	Pregabalin	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Nystatin	Nystatin	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Primidone	Primidone	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error